GMAB - GENMAB A/S
28.18
0.520 1.845%
Share volume: 1,403,989
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$27.66
0.52
0.02%
Summary score
34%
Profitability
49%
Dept financing
2%
Liquidity
50%
Performance
23%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
6.09%
Return on assets
6.05%
Return on sales
0%
Return on invested capital
-36.39%
Total debt ratio
7.04%
Debt ratio change over timeo
0%
Current Ratio
15.71%
Quick Ratio
0%
Cash Position Ratio
3.09%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
8.78%
Return on assets
9.66%
Return on sales
0%
Return on invested capital
17.9%
Total debt ratio
8.22%
Debt ratio change over timeo
0%
Current Ratio
15.54%
Quick Ratio
0%
Cash Position Ratio
5.41%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
18.52%
Return on assets
21.31%
Return on sales
0%
Return on invested capital
-708.79%
Total debt ratio
13.6%
Debt ratio change over time
0%
Current Ratio
9.53%
Quick Ratio
0%
Cash Position Ratio
3.29%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | GMAB | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 6.09% | 17.45% | 4.69% | -3.05% |
| Return on assets | 6.05% | 3.37% | 3.35% | 3.6% |
| Return on sales | 0% | 23.96% | 25.96% | 32.14% |
| Return on invested capital | -36.39% | 5.2% | 4.37% | 5.09% |
| Profitability | 34% | 83% | 62% | 64% |
| Total debt ratio | 7.04% | 77% | 57.66% | 101.18% |
| Debt ratio change over time | 0% | 0% | 10.55% | 69.81% |
| Dept financing | 2% | 19% | 18% | 50% |
| Current Ratio | 15.54% | 1.16% | 1.27% | 2.08% |
| Quick Ratio | 0% | 0.89% | 1.01% | 1.96% |
| Cash Position Ratio | 5.41% | 0.17% | 0.53% | 1.48% |
| Liquididy | 50% | 24% | 32% | 33% |
| Short-term ratios | GMAB | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 8.78% | 44.06% | 6.24% | -25.62% |
| Return on assets | 9.66% | 3.88% | 3.22% | 3.26% |
| Return on sales | 0% | 27.04% | 24.93% | 31.22% |
| Return on invested capital | 17.9% | 9.69% | 4.96% | 8.14% |
| Profitability | 55% | 70% | 39% | 45% |
| Total debt ratio | 8.22% | 91.8% | 61.39% | 105.33% |
| Debt ratio change over time | 0% | 0% | 12.93% | 15.97% |
| Dept financing | 2% | 22% | 35% | 50% |
| Current Ratio | 15.54% | 1.16% | 1.27% | 2.08% |
| Quick Ratio | 0% | 0.89% | 1.01% | 1.96% |
| Cash Position Ratio | 5.41% | 0.17% | 0.53% | 1.48% |
| Liquididy | 50% | 14% | 17% | 35% |